1. 78 T-Cell, MHC i, and tumor intrinsic gene signatures predict clinical benefit and resistance to tislelizumab monotherapy in pretreated PD-L1+ urothelial carcinoma. (10th December 2020) Authors: Ye, Dingwei; Zhou, Aiping; Zou, Qing; Li, Hanzhong; Fu, Cheng; Hu, Hailong; Huang, Jian; Shen, Wei; Zhang, Yun; Ma, Xiaopeng; Zhang, Pei; Huang, Ruiqi; Qiu, Xiusong; Zhang, Lilin; Bi, Feng Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A48 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 78 T-Cell, MHC i, and tumor intrinsic gene signatures predict clinical benefit and resistance to tislelizumab monotherapy in pretreated PD-L1+ urothelial carcinoma. (9th November 2020) Authors: Ye, Dingwei; Zhou, Aiping; Zou, Qing; Li, Hanzhong; Fu, Cheng; Hu, Hailong; Huang, Jian; Shen, Wei; Zhang, Yun; Ma, Xiaopeng; Zhang, Pei; Huang, Ruiqi; Qiu, Xiusong; Zhang, Lilin; Bi, Feng Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A85 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A high baseline HBV load and antiviral therapy affect the survival of patients with advanced HBV‐related HCC treated with sorafenib. (7th March 2015) Authors: Yang, Yu; Wen, Feng; Li, Jianliang; Zhang, Pengfei; Yan, Wenhui; Hao, Ping; Xia, Feng; Bi, Feng; Li, Qiu Journal: Liver international Issue: Volume 35:Number 9(2015:Sep.) Page Start: 2147 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Aflibercept plus FOLFIRI in Asian patients with pretreated metastatic colorectal cancer: a randomized Phase III study. (17th August 2018) Authors: Li, Jin; Xu, Ruihua; Qin, Shukui; Liu, Tianshu; Pan, Hongming; Xu, Jianming; Bi, Feng; Lim, Robert; Zhang, Suzhan; Ba, Yi; Bai, Yuxian; Fan, Nanfeng; Tsuji, Akihito; Yeh, Kun-Huei; Ma, Brigette; Wei, Vivian; Shi, Dongmei; Magherini, Emmanuelle; Shen, Lin Journal: Future oncology Issue: Volume 14:Number 20(2018) Page Start: 2031 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Bevacizumab Combined with S-1 and Raltitrexed for Patients with Metastatic Colorectal Cancer Refractory to Standard Therapies: A Phase II Study. (30th April 2021) Authors: Chen, Ye; Zhou, Yu-Wen; Cheng, Ke; Li, Zhi-Ping; Luo, De-Yun; Qiu, Meng; Li, Qiu; Wang, Xin; Shen, Ya-Li; Cao, Dan; Yang, Yu; Bi, Feng; Liu, Ji-Yan; Gou, Hong-Feng Journal: Oncologist Issue: Volume 26:Number 8(2021) Page Start: e1320 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Bevacizumab Combined with S‐1 and Raltitrexed for Patients with Metastatic Colorectal Cancer Refractory to Standard Therapies: A Phase II Study. (30th April 2021) Authors: Chen, Ye; Zhou, Yu‐Wen; Cheng, Ke; Li, Zhi‐Ping; Luo, De‐Yun; Qiu, Meng; Li, Qiu; Wang, Xin; Shen, Ya‐Li; Cao, Dan; Yang, Yu; Bi, Feng; Liu, Ji‐Yan; Gou, Hong‐Feng Journal: Oncologist Issue: Volume 26:Number 8(2021) Page Start: e1320 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Casp8 acts through A20 to inhibit PD‐L1 expression: The mechanism and its implication in immunotherapy. Issue 7 (20th May 2021) Authors: Zou, Jiahuan; Xia, Hongwei; Zhang, Chenliang; Xu, Huanji; Tang, Qiulin; Zhu, Gongmin; Li, Jielang; Bi, Feng Journal: Cancer science Issue: Volume 112:Issue 7(2021) Page Start: 2664 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. ChemInform Abstract: Preparation and Characterization of SrTiO3—ZnTe Nanocomposites for the Visible‐Light Photoconversion of Carbon Dioxide to Methane. Issue 4 (January 2015) Authors: Ehsan, Muhammad Fahad; Ashiq, Muhammad Naeem; Bi, Feng; Bi, Yiqing; Palanisamy, Sivakumar; He, Tao Journal: ChemInform Issue: Volume 46:Issue 4(2015) Page Start: no Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Clinical Characteristics of Patients With Solitary Pulmonary Mass After Radical Treatment for Primary Cancers: Pulmonary Metastasis or Second Primary Lung Cancer?. (1st July 2013) Authors: Ge, Jun; Gou, Hong-Feng; Chen, Ye; Cheng, Ke; Li, Long-Hao; Dong, Hang; Gao, Feng; Zhao, Feng; Men, Hai-Tao; Li, Qiu; Qiu, Meng; Su, Jing-Mei; Xu, Feng; Bi, Feng; Liu, Ji-Yan Journal: Cancer investigation Issue: Volume 31:Number 6(2013) Page Start: 397 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Clinicopathologic features, treatment, survival, and prognostic factors of combined hepatocellular and cholangiocarcinoma: A nomogram development based on SEER database and validation in multicenter study. Issue 7 (July 2022) Authors: Zhou, Yu-Wen; Li, Qing-Fang; Chen, Yue-Yun; Wang, Kai; Pu, Dan; Chen, Xiao-Rong; Li, Chun-Hong; Jiang, Li; Wang, Yan; Li, Qiu; Yang, Yu; Gou, Hong-Feng; Bi, Feng; Liu, Ji-Yan; Chen, Ye; Qiu, Meng Journal: European journal of surgical oncology Issue: Volume 48:Issue 7(2022) Page Start: 1559 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗